OEG - GME OSTK AQMS and PEI among premarket gainers
Edesa Biotech (EDSA) +97% on regulatory nod for sub set of phase2/3 EB05 COVID-19 study.Koss Corporation (KOSS) +84%.Phunware (PHUN) +65%.Vertex Energy (VTNR) +52%.Myomo (MYO) +33% on JV to manufacture and sell the company’s products in China.AIkido Pharma (AIKI) +25%.Phio Pharmaceuticals (PHIO) +18%.GameStop (GME) +18%.Aqua Metals (AQMS) +17%.Pennsylvania Real Estate Investment Trust (PEI) +16%.InVivo Therapeutics Holdings (NVIV) +13%.Motus GI Holdings (MOTS) +15%.Second Sight Medical Products (EYES) +13%.Selecta Biosciences (SELB) +15%.Orbital Energy Group (OEG) +14%.Atossa Therapeutics (ATOS) +13%.Overstock.com (OSTK) +13% after Medici Ventures transaction.Oramed Pharmaceuticals (ORMP) +13%.electroCore (ECOR) +12% on exclusive distribution agreement with RSK Medical in Canada.Allena Pharmaceuticals (ALNA) +13%.GSE Systems (GVP) +12%.GeoVax Labs (GOVX) +13%.TPG Pace Beneficial Finance (TPGY) +12%.CASI Pharmaceuticals (CASI) +12%.ASLAN Pharmaceuticals (ASLN) +12% as new research shows ASLAN003 to have the lowest potential for hepatotoxicity.
For further details see:
GME, OSTK, AQMS and PEI among premarket gainers